Published guidance, NICE advice and quality standards | Guidance

Showing 261 to 270 of 334

Sort by

Published guidance, NICE advice and quality standards
Title	Reference number	Published	Last updated
Ramucirumab for treating advanced gastric cancer or gastro–oesophageal junction adenocarcinoma previously treated with chemotherapy	TA378	27 January 2016	27 January 2016
Bladder cancer	QS106	17 December 2015	17 December 2015
Erlotinib and gefitinib for treating non-small-cell lung cancer that has progressed after prior chemotherapy	TA374	16 December 2015	16 December 2015
VivaScope 1500 and 3000 imaging systems for detecting skin cancer lesions	HTG388	11 November 2015	11 November 2015
Paclitaxel as albumin-bound nanoparticles with carboplatin for untreated non-small-cell lung cancer (terminated appraisal)	TA362	28 October 2015	28 October 2015
Bevacizumab for treating relapsed, platinum‑resistant epithelial ovarian, fallopian tube or primary peritoneal cancer (terminated appraisal)	TA353	26 August 2015	26 August 2015
Preoperative high dose rate brachytherapy for rectal cancer	HTG383	26 August 2015	26 August 2015
Nintedanib for previously treated locally advanced, metastatic, or locally recurrent non‑small‑cell lung cancer	TA347	22 July 2015	22 July 2015
Bladder cancer: diagnosis and management	NG2	25 February 2015	25 February 2015
Regorafenib for metastatic colorectal cancer after treatment for metastatic disease (terminated appraisal)	TA334	25 February 2015	25 February 2015